20
Bcn Peptides Sa, based in Spain, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is GANIRELIX ACETATE, with a corresponding US DMF Number 29585.
Remarkably, this DMF maintains an Active status since its submission on July 24, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 04, 2016, and payment made on September 18, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II